Indian drugmakers are expanding globally through major acquisitions, signaling a shift towards innovation in complex pharmaceuticals.

A record Sun Pharma acquisition signals global ambitions. But infrastructure, capital and policy gaps could stand in the way of India becoming an R&D powerhouse.

Indian drugmakers are expanding globally through major acquisitions, signaling a shift towards innovation in complex pharmaceuticals.